NOVOME BIOTECHNOLOGIES
Novome Biotechnologies, Inc. is a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The Company has developed the first-ever platform for controlled colonization of the gut with engineered bacteria, enabling first-in-class living therapeutics: Genetically Engineered Microbial Medicines (GEMMs). Novome is utilizing its proprietary GEMMs platform in its lead preclinical program in hyperoxaluria, which is focused on the development of a therapeutic strain of bacteria that degrades oxalate to prevent the formation of kidney stones. Efforts are also directed to the expansion of its proprietary synthetic biology platform into additional indications.
NOVOME BIOTECHNOLOGIES
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.novomebio.com
Total Employee:
11+
Status:
Active
Total Funding:
39.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Current Advisors List
Current Employees Featured
Founder
Investors List
Mayo Clinic Ventures
Mayo Clinic Ventures investment in Series A - Novome Biotechnologies
DCVC Bio
DCVC Bio investment in Series A - Novome Biotechnologies
Alta Partners
Alta Partners investment in Series A - Novome Biotechnologies
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Novome Biotechnologies
5AM Ventures
5AM Ventures investment in Series A - Novome Biotechnologies
National Science Foundation
National Science Foundation investment in Grant - Novome Biotechnologies
5AM Ventures
5AM Ventures investment in Seed Round - Novome Biotechnologies
National Science Foundation
National Science Foundation investment in Grant - Novome Biotechnologies
Key Employee Changes
Official Site Inspections
http://www.novomebio.com Semrush global rank: 5.7 M Semrush visits lastest month: 1.47 K
- Host name: 148.97.196.104.bc.googleusercontent.com
- IP address: 104.196.97.148
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Novome Biotechnologies"
Novome Biotechnologies - Crunchbase Company …
Novome Biotechnologies, Inc. is a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The Company has developed the first-ever platform for controlled …See details»
Novome Biotechnologies - PitchBook
Developer of a drug discovery platform intended to develop cell-based therapeutics.See details»
Novome Biotechnologies - LinkedIn
Novome is building genetically engineered microbial medicines (GEMMs) that perform defined activities in the human gut to treat chronic diseases.See details»
Novome Biotechnologies - Overview, News & Similar companies
Oct 19, 2021 · Novome Biotechnologies, Inc. is a clinical-stage biotechnology company developing engineered cellular therapies for the gut to treat chronic diseases.See details»
Novome Biotechnologies and Genentech Enter into a Strategic
Nov 10, 2021 · SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a clinical-stage biotechnology company developing engineered …See details»
Novome Biotechnologies - Craft
Novome Biotechnologies is a biotechnology company that engineers cell therapies for chronic diseases. Its platform enables controllable engraftment of genetically engineered microbial …See details»
Novome Biotechnologies and Genentech Enter into a Strategic ...
Novome is focused on treating chronic diseases with the first platform for the controlled and robust colonization of the human gut with engineered bacteria to deliver targeted therapeutic …See details»
Novome Biotechnologies - workinbiotech.com
Novome is engineering activities into the gut microbiome to treat chronic diseases. The gut microbiome performs many activities within the body such as food digestion and immune …See details»
Novome Biotechnologies Reports Positive Results from a Phase 1 …
Nov 17, 2021 · SOUTH SAN FRANCISCO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a clinical-stage biotechnology company developing engineered …See details»
Creating GEMMs for chronic disease - Nature
Novome’s novel platform develops genetically engineered microbial medicines (GEMMs) for chronic disease, offering the potential to act as a delivery system for novel therapeutic...See details»
Novome Biotechnologies Raises $43.5 Million Series B
Sep 13, 2022 · SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living …See details»
Novome Biotechnologies Initiates Phase 1/2a Study to
Jun 30, 2021 · Novome Biotechnologies, Inc. is a biotechnology company developing engineered cellular therapies for the gut to treat chronic diseases.See details»
Colorcon Ventures Invests in Novome Biotechnologies, an …
HARLEYSVILLE, Pa., Sept. 15, 2022 /PRNewswire/ -- Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Novome Biotechnologies, a clinical-stage company that …See details»
Novome Biotechnologies Initiates Phase 1/2a Study to Evaluate ...
Jun 30, 2021 · SOUTH SAN FRANCISCO, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living …See details»
Novome Biotechnologies CEO and Key Executive Team | Craft.co
Novome Biotechnologies's key executives include Blake Wise and 6 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via …See details»
Novome raises $43.5M for therapeutically engineered microbes
Sep 15, 2022 · U.S. biotech company Novome Biotechnologies, Inc., has closed a $43.5 million series B financing round. The financing was led by Tencent, and includes new investors …See details»
Novome Biotechnologies Reports Positive Results from a
Nov 17, 2021 · SOUTH SAN FRANCISCO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a clinical-stage biotechnology company developing engineered …See details»
Novome Biotechnologies Appoints Dr. Lachy McLean as Chief
Jun 22, 2021 · SOUTH SAN FRANCISCO, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living …See details»
Novome Biotechnologies, Inc. | Insights
Nov 18, 2021 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Novome Biotechnologies Raises $43.5 Million Series B Financing to ...
Sep 13, 2022 · SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living …See details»